Clinic
Prescott Healthcare Solutions LLC
Prescott Healthcare Solutions LLC was paid $13.24M by Medicaid between Jan 2018 and Nov 2024, across 150 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 60% of everything it billed.
33Billing provider infoPRESCOTT HEALTHCARE SOLUTIONS LLC
PRESCOTT, AZ 86301
PRESCOTT, AZ 86301
33aNPI1821454505assigned 01/11/2016
33bProvider typePrimary Care Clinic/Center
28Total paid$13.24M
24GClaims418,643
24DCodes billed150
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Arizona
Rank by total paid#7 of 104
Median peer was paid$181K
This provider vs. median73×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 41,142 | $1.32M | |
| 2019 | 50,315 | $1.79M | |
| 2020 | 55,398 | $1.30M | |
| 2021 | 47,152 | $1.32M | |
| 2022 | 38,272 | $1.27M | |
| 2023 | 87,491 | $2.89M | |
| 2024incomplete | 98,873 | $3.35M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 60% | 143,747 | 123,671 | $7.99M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.3% | 27,617 | 24,861 | $1.10M |
| 99401 | 5.3% | 27,523 | 24,374 | $706K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.1% | 9,147 | 8,214 | $410K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.9% | 4,184 | 3,773 | $248K |
| 99457 | 1.7% | 9,241 | 9,161 | $229K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.6% | 2,720 | 2,624 | $210K |
| 95923 | 1.6% | 2,654 | 2,561 | $210K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.5% | 2,821 | 2,712 | $197K |
| 96127 | 1.2% | 43,411 | 34,719 | $156K | |
| 94060 | 1.2% | 4,166 | 3,868 | $153K | |
| 95921 | 1.1% | 2,662 | 2,566 | $145K |
138 more codes
| 99454 | <1% | 4,396 | $111K | |
| 93000 | <1% | 10,054 | $104K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,184 | $90K |
| 99458 | <1% | 5,587 | $87K | |
| 93922 | <1% | 1,542 | $73K | |
| 99493 | <1% | 1,098 | $66K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,562 | $61K |
| 94200 | <1% | 3,790 | $58K | |
| 94690 | <1% | 1,606 | $53K | |
| 93880 | <1% | 470 | $49K | |
| 99385 | <1% | 606 | $48K | |
| 99205 | Prolong outpt/office vis | <1% | 633 | $46K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 855 | $41K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 463 | $35K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 325 | $34K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 407 | $33K |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,779 | $32K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,004 | $30K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 333 | $29K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 584 | $29K |
| 93978 | <1% | 300 | $28K | |
| 80050 | General health panel | <1% | 917 | $28K |
| 99490 | Ccm add 20min | <1% | 8,881 | $26K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,881 | $26K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 262 | $23K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,276 | $22K |
| 93925 | <1% | 139 | $22K | |
| 99386 | <1% | 215 | $22K | |
| 80061 | Lipid panel | <1% | 2,018 | $20K |
| 95806 | <1% | 129 | $16K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 708 | $12K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 120 | $10K |
| 93272 | <1% | 730 | $10K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 170 | $10K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 875 | $9K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 692 | $8K |
| 99439 | <1% | 858 | $8K | |
| 81025 | <1% | 1,156 | $7K | |
| 81002 | <1% | 2,624 | $6K | |
| 90756 | <1% | 326 | $5K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 165 | $4K |
| 90688 | <1% | 371 | $4K | |
| 99397 | <1% | 123 | $4K | |
| 93356 | <1% | 175 | $4K | |
| 82607 | <1% | 779 | $3K | |
| 99497 | <1% | 208 | $3K | |
| 87428 | <1% | 127 | $3K | |
| 99453 | <1% | 250 | $3K | |
| 80053 | Comprehensive metabolic panel | <1% | 519 | $3K |
| 96160 | <1% | 1,087 | $2K | |
| 96116 | <1% | 94 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 518 | $2K |
| 99491 | Ccm add 20min | <1% | 385 | $1K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 13 | $1K |
| 96138 | <1% | 124 | $1K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 17 | $1K |
| 99443 | <1% | 17 | $1K | |
| 96120 | <1% | 30 | $925.92 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 226 | $787.71 |
| 84439 | <1% | 115 | $722.78 | |
| 80305 | <1% | 98 | $715.76 | |
| 99354 | <1% | 48 | $655.19 | |
| 76706 | <1% | 13 | $650.34 | |
| 99402 | <1% | 16 | $640.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 41 | $556.56 |
| 82043 | <1% | 117 | $526.06 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 346 | $426.73 |
| 99492 | <1% | 13 | $417.69 | |
| 99494 | <1% | 12 | $320.95 | |
| 90715 | <1% | 12 | $315.75 | |
| 82746 | <1% | 517 | $305.57 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 91 | $282.70 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 128 | $264.63 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 155 | $216.03 |
| 11721 | <1% | 21 | $176.39 | |
| 83001 | <1% | 12 | $160.35 | |
| 83002 | <1% | 12 | $159.79 | |
| 99406 | <1% | 3,244 | $134.65 | |
| 99407 | <1% | 2,847 | $125.44 | |
| 36410 | <1% | 14 | $119.31 | |
| 94664 | <1% | 17 | $113.67 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 481 | $88.67 |
| 96119 | <1% | 16 | $72.37 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 2,640 | $69.34 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 141 | $64.91 |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 1,840 | $59.89 |
| 99173 | <1% | 100 | $58.35 | |
| 82570 | <1% | 15 | $53.80 | |
| 84481 | <1% | 39 | $51.84 | |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | <1% | 707 | $45.19 |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | <1% | 46 | $43.12 |
| 99408 | <1% | 1,898 | $27.98 | |
| 99473 | <1% | 17 | $24.50 | |
| 1160F | <1% | 14,954 | $18.82 | |
| 96146 | <1% | 13 | $18.48 | |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | <1% | 59 | $10.74 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 4,032 | $3.16 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 14 | $1.29 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 18 | $1.20 |
| 1159F | <1% | 13 | $0.03 | |
| G8482 | Influenza immunization administered or previously received | 0% | 168 | $0.00 |
| 4004F | 0% | 2,153 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 22 | $0.00 |
| 96136 | 0% | 274 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 915 | $0.00 |
| G9621 | Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling | 0% | 33 | $0.00 |
| 3078F | 0% | 1,498 | $0.00 | |
| 90671 | 0% | 18 | $0.00 | |
| G9451 | Patient received one-time screening for hcv infection | 0% | 324 | $0.00 |
| G8477 | Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhg | 0% | 330 | $0.00 |
| 99072 | 0% | 156 | $0.00 | |
| 99409 | 0% | 406 | $0.00 | |
| 96130 | 0% | 72 | $0.00 | |
| 87652 | 0% | 24 | $0.00 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 22 | $0.00 |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 0% | 14 | $0.00 |
| G8404 | Lower extremity neurological exam performed and documented | 0% | 18 | $0.00 |
| 3050F | 0% | 29 | $0.00 | |
| 1158F | 0% | 12 | $0.00 | |
| 87400 | 0% | 34 | $0.00 | |
| 3079F | 0% | 1,163 | $0.00 | |
| 2010F | 0% | 2,594 | $0.00 | |
| 3074F | 0% | 2,039 | $0.00 | |
| G0432 | Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening | 0% | 592 | $0.00 |
| 1125F | 0% | 1,302 | $0.00 | |
| 3048F | 0% | 597 | $0.00 | |
| 3049F | 0% | 98 | $0.00 | |
| 1157F | 0% | 12 | $0.00 | |
| 4450F | 0% | 56 | $0.00 | |
| 3075F | 0% | 783 | $0.00 | |
| 0001F | 0% | 155 | $0.00 | |
| 3008F | 0% | 931 | $0.00 | |
| G9273 | Blood pressure has a systolic value of < 140 and a diastolic value of < 90 | 0% | 37 | $0.00 |
| 87486 | 0% | 22 | $0.00 | |
| 87581 | 0% | 22 | $0.00 | |
| 1000F | 0% | 68 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 29 | $0.00 |
| 1126F | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialO'NEIL, MICHAEL (CEO)
| Provider | Location | Paid |
|---|---|---|
| Old Pueblo Healthcare LLC | Tucson, AZ | $3.86M |
| Nashoba Vision Associates INC | Groton, MA | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.